Skip to content
healthcare.dev

Eribulin Mesylate

NDC 68001-656, Eribulin Mesylate, solution, from BluePoint Laboratories.

Product NDC
68001-656
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214850
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-656 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
68001-656-41680010656411 VIAL, SINGLE-DOSE in 1 CARTON (68001-656-41) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1a1a9cff-d5da-4232-b98f-26f55208dfc4
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68001-656

Use it

Look up 68001-656 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-656 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-656. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.